大腿カニューレのグローバル市場予測2023-2029

◆英語タイトル:Global Femoral Cannula Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23MY4712)◆商品コード:LP23MY4712
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「大腿カニューレのグローバル市場」は、過去の販売実績から2022年の世界の大腿カニューレの総販売量を検討し、2023年から2029年の予測される大腿カニューレの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の大腿カニューレの市場規模を掲載し、XXX百万米ドル規模の世界の大腿カニューレ市場の詳細な分析を提供します。本インサイトレポートは、世界の大腿カニューレ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の大腿カニューレ市場における各社の独自のポジションをより深く理解するために、大腿カニューレ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の大腿カニューレ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。大腿カニューレの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。大腿カニューレの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。大腿カニューレのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

大腿カニューレの世界主要メーカーとしては、Medtronic、 Edward Lifescience、 LivaNova、 Surge Cardiovascular、 Changzhou KangXin Medical Instruments Co., Ltd.、 Chalice Medical Ltd.、 Xenios AGなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の大腿カニューレ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では大腿カニューレ市場をセグメンテーションし、種類別 (ユニポーラ、バイポーラ)、用途別 (従来型体外循環手術、体外式膜型人工肺(ECMO)、血液透析、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:ユニポーラ、バイポーラ

・用途別区分:従来型体外循環手術、体外式膜型人工肺(ECMO)、血液透析、その他

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の大腿カニューレ市場の10年間の市場状況・展望は?
・世界および地域別に見た大腿カニューレ市場成長の要因は何か?
・大腿カニューレの市場機会はエンドマーケットの規模によってどのように変化するのか?
・大腿カニューレのタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:大腿カニューレの年間販売量2018-2029、地域別現状・将来分析
・大腿カニューレの種類別セグメント:ユニポーラ、バイポーラ
・大腿カニューレの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・大腿カニューレの用途別セグメント:従来型体外循環手術、体外式膜型人工肺(ECMO)、血液透析、その他
・大腿カニューレの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の大腿カニューレ市場
・企業別のグローバル大腿カニューレ市場データ:2018-2023年の年間販売量、市場シェア
・企業別の大腿カニューレの年間売上:2018-2023年の売上、市場シェア
・企業別の大腿カニューレ販売価格
・主要企業の大腿カニューレ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

大腿カニューレの地域別レビュー
・地域別の大腿カニューレ市場規模2018-2023:年間販売量、売上
・主要国別の大腿カニューレ市場規模2018-2023:年間販売量、売上
・南北アメリカの大腿カニューレ販売の成長
・アジア太平洋の大腿カニューレ販売の成長
・ヨーロッパの大腿カニューレ販売の成長
・中東・アフリカの大腿カニューレ販売の成長

南北アメリカ市場
・南北アメリカの国別の大腿カニューレ販売量、売上(2018-2023)
・南北アメリカの大腿カニューレの種類別販売量
・南北アメリカの大腿カニューレの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の大腿カニューレ販売量、売上(2018-2023)
・アジア太平洋の大腿カニューレの種類別販売量
・アジア太平洋の大腿カニューレの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の大腿カニューレ販売量、売上(2018-2023)
・ヨーロッパの大腿カニューレの種類別販売量
・ヨーロッパの大腿カニューレの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の大腿カニューレ販売量、売上(2018-2023)
・中東・アフリカの大腿カニューレの種類別販売量
・中東・アフリカの大腿カニューレの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・大腿カニューレの製造コスト構造分析
・大腿カニューレの製造プロセス分析
・大腿カニューレの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・大腿カニューレの主要なグローバル販売業者
・大腿カニューレの主要なグローバル顧客

地域別の大腿カニューレ市場予測レビュー
・地域別の大腿カニューレ市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・大腿カニューレの種類別市場規模予測
・大腿カニューレの用途別市場規模予測

主要企業分析
Medtronic、 Edward Lifescience、 LivaNova、 Surge Cardiovascular、 Changzhou KangXin Medical Instruments Co., Ltd.、 Chalice Medical Ltd.、 Xenios AG
・企業情報
・大腿カニューレ製品
・大腿カニューレ販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
LPI (LP Information)’ newest research report, the “Femoral Cannula Industry Forecast” looks at past sales and reviews total world Femoral Cannula sales in 2022, providing a comprehensive analysis by region and market sector of projected Femoral Cannula sales for 2023 through 2029. With Femoral Cannula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Femoral Cannula industry.
This Insight Report provides a comprehensive analysis of the global Femoral Cannula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Femoral Cannula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Femoral Cannula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Femoral Cannula and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Femoral Cannula.
The global Femoral Cannula market size is projected to grow from US$ 34 million in 2022 to US$ 51 million in 2029; it is expected to grow at a CAGR of 51 from 2023 to 2029.
Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.
The main producers are mainly in Europe and the United States.
This report presents a comprehensive overview, market shares, and growth opportunities of Femoral Cannula market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Unipolar
Bipolar
Segmentation by application
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG
Key Questions Addressed in this Report
What is the 10-year outlook for the global Femoral Cannula market?
What factors are driving Femoral Cannula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Femoral Cannula market opportunities vary by end market size?
How does Femoral Cannula break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Femoral Cannula Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Femoral Cannula by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Femoral Cannula by Country/Region, 2018, 2022 & 2029
2.2 Femoral Cannula Segment by Type
2.2.1 Unipolar
2.2.2 Bipolar
2.3 Femoral Cannula Sales by Type
2.3.1 Global Femoral Cannula Sales Market Share by Type (2018-2023)
2.3.2 Global Femoral Cannula Revenue and Market Share by Type (2018-2023)
2.3.3 Global Femoral Cannula Sale Price by Type (2018-2023)
2.4 Femoral Cannula Segment by Application
2.4.1 Traditional extracorporeal circulation surgery
2.4.2 Extracorporeal membrane oxygenation (ECMO)
2.4.3 Hemodialysis
2.4.4 Other
2.5 Femoral Cannula Sales by Application
2.5.1 Global Femoral Cannula Sale Market Share by Application (2018-2023)
2.5.2 Global Femoral Cannula Revenue and Market Share by Application (2018-2023)
2.5.3 Global Femoral Cannula Sale Price by Application (2018-2023)
3 Global Femoral Cannula by Company
3.1 Global Femoral Cannula Breakdown Data by Company
3.1.1 Global Femoral Cannula Annual Sales by Company (2018-2023)
3.1.2 Global Femoral Cannula Sales Market Share by Company (2018-2023)
3.2 Global Femoral Cannula Annual Revenue by Company (2018-2023)
3.2.1 Global Femoral Cannula Revenue by Company (2018-2023)
3.2.2 Global Femoral Cannula Revenue Market Share by Company (2018-2023)
3.3 Global Femoral Cannula Sale Price by Company
3.4 Key Manufacturers Femoral Cannula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Femoral Cannula Product Location Distribution
3.4.2 Players Femoral Cannula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Femoral Cannula by Geographic Region
4.1 World Historic Femoral Cannula Market Size by Geographic Region (2018-2023)
4.1.1 Global Femoral Cannula Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Femoral Cannula Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Femoral Cannula Market Size by Country/Region (2018-2023)
4.2.1 Global Femoral Cannula Annual Sales by Country/Region (2018-2023)
4.2.2 Global Femoral Cannula Annual Revenue by Country/Region (2018-2023)
4.3 Americas Femoral Cannula Sales Growth
4.4 APAC Femoral Cannula Sales Growth
4.5 Europe Femoral Cannula Sales Growth
4.6 Middle East & Africa Femoral Cannula Sales Growth
5 Americas
5.1 Americas Femoral Cannula Sales by Country
5.1.1 Americas Femoral Cannula Sales by Country (2018-2023)
5.1.2 Americas Femoral Cannula Revenue by Country (2018-2023)
5.2 Americas Femoral Cannula Sales by Type
5.3 Americas Femoral Cannula Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Femoral Cannula Sales by Region
6.1.1 APAC Femoral Cannula Sales by Region (2018-2023)
6.1.2 APAC Femoral Cannula Revenue by Region (2018-2023)
6.2 APAC Femoral Cannula Sales by Type
6.3 APAC Femoral Cannula Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Femoral Cannula by Country
7.1.1 Europe Femoral Cannula Sales by Country (2018-2023)
7.1.2 Europe Femoral Cannula Revenue by Country (2018-2023)
7.2 Europe Femoral Cannula Sales by Type
7.3 Europe Femoral Cannula Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Femoral Cannula by Country
8.1.1 Middle East & Africa Femoral Cannula Sales by Country (2018-2023)
8.1.2 Middle East & Africa Femoral Cannula Revenue by Country (2018-2023)
8.2 Middle East & Africa Femoral Cannula Sales by Type
8.3 Middle East & Africa Femoral Cannula Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Femoral Cannula
10.3 Manufacturing Process Analysis of Femoral Cannula
10.4 Industry Chain Structure of Femoral Cannula
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Femoral Cannula Distributors
11.3 Femoral Cannula Customer
12 World Forecast Review for Femoral Cannula by Geographic Region
12.1 Global Femoral Cannula Market Size Forecast by Region
12.1.1 Global Femoral Cannula Forecast by Region (2024-2029)
12.1.2 Global Femoral Cannula Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Femoral Cannula Forecast by Type
12.7 Global Femoral Cannula Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Femoral Cannula Product Portfolios and Specifications
13.1.3 Medtronic Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Edward Lifescience
13.2.1 Edward Lifescience Company Information
13.2.2 Edward Lifescience Femoral Cannula Product Portfolios and Specifications
13.2.3 Edward Lifescience Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Edward Lifescience Main Business Overview
13.2.5 Edward Lifescience Latest Developments
13.3 LivaNova
13.3.1 LivaNova Company Information
13.3.2 LivaNova Femoral Cannula Product Portfolios and Specifications
13.3.3 LivaNova Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 LivaNova Main Business Overview
13.3.5 LivaNova Latest Developments
13.4 Surge Cardiovascular
13.4.1 Surge Cardiovascular Company Information
13.4.2 Surge Cardiovascular Femoral Cannula Product Portfolios and Specifications
13.4.3 Surge Cardiovascular Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Surge Cardiovascular Main Business Overview
13.4.5 Surge Cardiovascular Latest Developments
13.5 Changzhou KangXin Medical Instruments Co., Ltd.
13.5.1 Changzhou KangXin Medical Instruments Co., Ltd. Company Information
13.5.2 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolios and Specifications
13.5.3 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Changzhou KangXin Medical Instruments Co., Ltd. Main Business Overview
13.5.5 Changzhou KangXin Medical Instruments Co., Ltd. Latest Developments
13.6 Chalice Medical Ltd.
13.6.1 Chalice Medical Ltd. Company Information
13.6.2 Chalice Medical Ltd. Femoral Cannula Product Portfolios and Specifications
13.6.3 Chalice Medical Ltd. Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Chalice Medical Ltd. Main Business Overview
13.6.5 Chalice Medical Ltd. Latest Developments
13.7 Xenios AG
13.7.1 Xenios AG Company Information
13.7.2 Xenios AG Femoral Cannula Product Portfolios and Specifications
13.7.3 Xenios AG Femoral Cannula Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Xenios AG Main Business Overview
13.7.5 Xenios AG Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Femoral Cannula Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Femoral Cannula Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Unipolar
Table 4. Major Players of Bipolar
Table 5. Global Femoral Cannula Sales by Type (2018-2023) & (K Units)
Table 6. Global Femoral Cannula Sales Market Share by Type (2018-2023)
Table 7. Global Femoral Cannula Revenue by Type (2018-2023) & ($ million)
Table 8. Global Femoral Cannula Revenue Market Share by Type (2018-2023)
Table 9. Global Femoral Cannula Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Femoral Cannula Sales by Application (2018-2023) & (K Units)
Table 11. Global Femoral Cannula Sales Market Share by Application (2018-2023)
Table 12. Global Femoral Cannula Revenue by Application (2018-2023)
Table 13. Global Femoral Cannula Revenue Market Share by Application (2018-2023)
Table 14. Global Femoral Cannula Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Femoral Cannula Sales by Company (2018-2023) & (K Units)
Table 16. Global Femoral Cannula Sales Market Share by Company (2018-2023)
Table 17. Global Femoral Cannula Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Femoral Cannula Revenue Market Share by Company (2018-2023)
Table 19. Global Femoral Cannula Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Femoral Cannula Producing Area Distribution and Sales Area
Table 21. Players Femoral Cannula Products Offered
Table 22. Femoral Cannula Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Femoral Cannula Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Femoral Cannula Sales Market Share Geographic Region (2018-2023)
Table 27. Global Femoral Cannula Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Femoral Cannula Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Femoral Cannula Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Femoral Cannula Sales Market Share by Country/Region (2018-2023)
Table 31. Global Femoral Cannula Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Femoral Cannula Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Femoral Cannula Sales by Country (2018-2023) & (K Units)
Table 34. Americas Femoral Cannula Sales Market Share by Country (2018-2023)
Table 35. Americas Femoral Cannula Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Femoral Cannula Revenue Market Share by Country (2018-2023)
Table 37. Americas Femoral Cannula Sales by Type (2018-2023) & (K Units)
Table 38. Americas Femoral Cannula Sales by Application (2018-2023) & (K Units)
Table 39. APAC Femoral Cannula Sales by Region (2018-2023) & (K Units)
Table 40. APAC Femoral Cannula Sales Market Share by Region (2018-2023)
Table 41. APAC Femoral Cannula Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Femoral Cannula Revenue Market Share by Region (2018-2023)
Table 43. APAC Femoral Cannula Sales by Type (2018-2023) & (K Units)
Table 44. APAC Femoral Cannula Sales by Application (2018-2023) & (K Units)
Table 45. Europe Femoral Cannula Sales by Country (2018-2023) & (K Units)
Table 46. Europe Femoral Cannula Sales Market Share by Country (2018-2023)
Table 47. Europe Femoral Cannula Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Femoral Cannula Revenue Market Share by Country (2018-2023)
Table 49. Europe Femoral Cannula Sales by Type (2018-2023) & (K Units)
Table 50. Europe Femoral Cannula Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Femoral Cannula Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Femoral Cannula Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Femoral Cannula Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Femoral Cannula Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Femoral Cannula Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Femoral Cannula Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Femoral Cannula
Table 58. Key Market Challenges & Risks of Femoral Cannula
Table 59. Key Industry Trends of Femoral Cannula
Table 60. Femoral Cannula Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Femoral Cannula Distributors List
Table 63. Femoral Cannula Customer List
Table 64. Global Femoral Cannula Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Femoral Cannula Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Femoral Cannula Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Femoral Cannula Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Femoral Cannula Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Femoral Cannula Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Femoral Cannula Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Femoral Cannula Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Femoral Cannula Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Femoral Cannula Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Femoral Cannula Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Femoral Cannula Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Femoral Cannula Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Femoral Cannula Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Femoral Cannula Product Portfolios and Specifications
Table 80. Medtronic Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Edward Lifescience Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 84. Edward Lifescience Femoral Cannula Product Portfolios and Specifications
Table 85. Edward Lifescience Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Edward Lifescience Main Business
Table 87. Edward Lifescience Latest Developments
Table 88. LivaNova Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 89. LivaNova Femoral Cannula Product Portfolios and Specifications
Table 90. LivaNova Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. LivaNova Main Business
Table 92. LivaNova Latest Developments
Table 93. Surge Cardiovascular Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 94. Surge Cardiovascular Femoral Cannula Product Portfolios and Specifications
Table 95. Surge Cardiovascular Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Surge Cardiovascular Main Business
Table 97. Surge Cardiovascular Latest Developments
Table 98. Changzhou KangXin Medical Instruments Co., Ltd. Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 99. Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolios and Specifications
Table 100. Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Changzhou KangXin Medical Instruments Co., Ltd. Main Business
Table 102. Changzhou KangXin Medical Instruments Co., Ltd. Latest Developments
Table 103. Chalice Medical Ltd. Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 104. Chalice Medical Ltd. Femoral Cannula Product Portfolios and Specifications
Table 105. Chalice Medical Ltd. Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Chalice Medical Ltd. Main Business
Table 107. Chalice Medical Ltd. Latest Developments
Table 108. Xenios AG Basic Information, Femoral Cannula Manufacturing Base, Sales Area and Its Competitors
Table 109. Xenios AG Femoral Cannula Product Portfolios and Specifications
Table 110. Xenios AG Femoral Cannula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Xenios AG Main Business
Table 112. Xenios AG Latest Developments
List of Figures
Figure 1. Picture of Femoral Cannula
Figure 2. Femoral Cannula Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Femoral Cannula Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Femoral Cannula Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Femoral Cannula Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Unipolar
Figure 10. Product Picture of Bipolar
Figure 11. Global Femoral Cannula Sales Market Share by Type in 2022
Figure 12. Global Femoral Cannula Revenue Market Share by Type (2018-2023)
Figure 13. Femoral Cannula Consumed in Traditional extracorporeal circulation surgery
Figure 14. Global Femoral Cannula Market: Traditional extracorporeal circulation surgery (2018-2023) & (K Units)
Figure 15. Femoral Cannula Consumed in Extracorporeal membrane oxygenation (ECMO)
Figure 16. Global Femoral Cannula Market: Extracorporeal membrane oxygenation (ECMO) (2018-2023) & (K Units)
Figure 17. Femoral Cannula Consumed in Hemodialysis
Figure 18. Global Femoral Cannula Market: Hemodialysis (2018-2023) & (K Units)
Figure 19. Femoral Cannula Consumed in Other
Figure 20. Global Femoral Cannula Market: Other (2018-2023) & (K Units)
Figure 21. Global Femoral Cannula Sales Market Share by Application (2022)
Figure 22. Global Femoral Cannula Revenue Market Share by Application in 2022
Figure 23. Femoral Cannula Sales Market by Company in 2022 (K Units)
Figure 24. Global Femoral Cannula Sales Market Share by Company in 2022
Figure 25. Femoral Cannula Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Femoral Cannula Revenue Market Share by Company in 2022
Figure 27. Global Femoral Cannula Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Femoral Cannula Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Femoral Cannula Sales 2018-2023 (K Units)
Figure 30. Americas Femoral Cannula Revenue 2018-2023 ($ Millions)
Figure 31. APAC Femoral Cannula Sales 2018-2023 (K Units)
Figure 32. APAC Femoral Cannula Revenue 2018-2023 ($ Millions)
Figure 33. Europe Femoral Cannula Sales 2018-2023 (K Units)
Figure 34. Europe Femoral Cannula Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Femoral Cannula Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Femoral Cannula Revenue 2018-2023 ($ Millions)
Figure 37. Americas Femoral Cannula Sales Market Share by Country in 2022
Figure 38. Americas Femoral Cannula Revenue Market Share by Country in 2022
Figure 39. Americas Femoral Cannula Sales Market Share by Type (2018-2023)
Figure 40. Americas Femoral Cannula Sales Market Share by Application (2018-2023)
Figure 41. United States Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Femoral Cannula Sales Market Share by Region in 2022
Figure 46. APAC Femoral Cannula Revenue Market Share by Regions in 2022
Figure 47. APAC Femoral Cannula Sales Market Share by Type (2018-2023)
Figure 48. APAC Femoral Cannula Sales Market Share by Application (2018-2023)
Figure 49. China Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Femoral Cannula Sales Market Share by Country in 2022
Figure 57. Europe Femoral Cannula Revenue Market Share by Country in 2022
Figure 58. Europe Femoral Cannula Sales Market Share by Type (2018-2023)
Figure 59. Europe Femoral Cannula Sales Market Share by Application (2018-2023)
Figure 60. Germany Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Femoral Cannula Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Femoral Cannula Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Femoral Cannula Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Femoral Cannula Sales Market Share by Application (2018-2023)
Figure 69. Egypt Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Femoral Cannula Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Femoral Cannula in 2022
Figure 75. Manufacturing Process Analysis of Femoral Cannula
Figure 76. Industry Chain Structure of Femoral Cannula
Figure 77. Channels of Distribution
Figure 78. Global Femoral Cannula Sales Market Forecast by Region (2024-2029)
Figure 79. Global Femoral Cannula Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Femoral Cannula Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Femoral Cannula Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Femoral Cannula Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Femoral Cannula Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 大腿カニューレのグローバル市場予測2023-2029(Global Femoral Cannula Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆